AGM Address
Filed with ASX · · 17 pages · English
On 6ix: 6ix.com/news/agm-address-3
Good morning ladies and gentlemen, welcome to the 2019 Annual General Meeting for NeuroScientific Biopharmaceuticals Limited. My name is Brian Leedman and I’m Chairman of NeuroScientific. I will also Chair today’s meeting. Thank you for taking the time to attend this morning. I note that it is 10:00am and we have quorum, so I will officially declare this AGM open for proceedings. I would now like
Neuroscientific Biopharmaceuticals Ltd. on 6ix
Earlier from Neuroscientific Biopharmaceuticals
- EmtinB Can Become a Revolutionary Treatment for Glaucoma
- NSB Receives R&D Advanced Overseas Finding
- NSB - FInal Data Received from Spinal Cord Injury Model
- NSB - Breakthrough results from Spinal Cord Injury Model
- Appendix 4D & Half-Year Financial Statements
Later from Neuroscientific Biopharmaceuticals
- NSB - Company Update
- CVN Model Indicates Neuroprotective Properties of EmtinB
- Additional US Patent granted
- Positive Results in Glaucoma Pig Model
- Positive Results in MS Study
Follow Neuroscientific Biopharmaceuticals into a list and get an email when it puts out news.
Follow Neuroscientific Biopharmaceuticals